'End-stage' hypertrophic cardiomyopathy: From mystery to model

Nature Clinical Practice Cardiovascular Medicine

Volumn 4, Issue 5, 2007, Pages 232-233

  Yacoub, Magdi H ^a,b   Olivotto, Iacopo ^c   Cecchi, Franco ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF FLORENCE   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; MYOSIN HEAVY CHAIN BETA;

ASSISTED CIRCULATION; CLINICAL FEATURE; DEFIBRILLATOR; DIASTOLIC DYSFUNCTION; GENE MUTATION; GENETIC HETEROGENEITY; HEART FAILURE; HEART MUSCLE FIBROSIS; HEART VENTRICLE PACING; HEART VENTRICLE REMODELING; HEART VENTRICLE WALL; HISTOLOGY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SUDDEN DEATH; SYSTOLIC DYSFUNCTION; TERMINAL DISEASE; AGE; CONGESTIVE HEART FAILURE; DISEASE COURSE; HEALTH; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; INCIDENCE; PHYSIOLOGY; PREVALENCE;

AGE FACTORS; CARDIOMYOPATHY, HYPERTROPHIC; DISEASE PROGRESSION; HEART FAILURE, CONGESTIVE; HUMANS; INCIDENCE; MYOCARDIAL CONTRACTION; PREVALENCE; PROGNOSIS; VENTRICULAR FUNCTION, LEFT; WORLD HEALTH;

EID: 34247598897     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio0859     Document Type: Review

References (10)

1. Cecchi F et al. (2005) Hypertrophic cardiomyopathy in the community: Why we should care. Nat Clin Pract Cardiovasc Med 2 324-325
2. Arad M et al. (2002) Phenotypic diversity in hypertrophic cardiomyopathy. Hum Mol Genet 11: 2499-2506
3. Harris KM et al. (2006) Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 114: 216-225
4. Olivotto I et al. (2006) Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J Am Coll Cardiol 47: 1043-1048
5. Tardiff JC (2005) Sarcomeric proteins and familial hypertrophic cardiomyopathy: Linking mutations in structural proteins to complex cardiovascular phenotypes. Heart Fail Rev 10: 237-248
6. Knoll R et al. (2002) The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 111: 943-955
7. Baudino TA et al. (2006) Cardiac fibroblasts: Friend or foe? Am J Physiol Heart Circ Physiol 291: H1015-H1026
8. Hwang JJ et al. (2002) Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol Genomics 10: 31-44
9. Hall JL et al. (2007) Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. Eur Heart J 28: 613-627
10. Birks EJ et al. (2006) Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 355: 1873-1884